Through our Early-Stage Investigator Grant Program, CCC hopes to accelerate the development of therapeutic treatments and disease-modifying advancements for those living with CHD2-related disorders. This grant program is designed to facilitate preliminary investigations that will potentially lay the groundwork for subsequent grants from the government, industry, or other funding sources, including Coalition to Cure CHD2.
CCC is interested in supporting research that advances the understanding of the cellular, molecular, genetic, and systems-level mechanisms of CHD2-related disorders. However, priority will be given to innovative projects which could potentially lead to therapeutic treatments or a cure for those with CHD2-related disorders.
Contact information submitted to the ERC will be used to help connect epilepsy researchers with funding organizations exclusively. Your email will not be sold or shared with organizations unrelated to this effort.
Please enter your email address below. If you are already a member you will be logged in.
If you are not a current member, you will be registered automatically.
Please enter a valid email address.Your email address has been registered. Please check your email for further instructions.
The email address you entered is associated with an existing account.